Description |
Product Type |
Product Size |
Syrup |
1'S |
Product Company |
Sandoz |
Pizotifen 60ml |
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Sandoz |
|
Product Type |
Product Size |
Tablet |
30'S |
Product Company |
Pfizer |
Amlodipine besylate 5mg
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Fresenius kabi |
Cytarabine 500mg/50ml |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Himmel Pharma
|
Carboplatin 150mg/15ml |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Macter Pharma
|
Zoledronic Acid 4mg/5ml
|
Content | Pizotifen belongs to the class of antamines and is related to cyproheptadine. It is a potent serotonin and tryptamine antagonist that has been used for migraine prevention for many years. | Gemcitabine is a cytidine analog with two fluorine atoms.As a prodrug, gemcitabine is transformed into its active metabolites that work by replacing the building blocks of nucleic acids during DNA elongation, arresting tumour growth and promoting apoptosis of malignant cells. | Amlodipine is an oral antihypertensive medicine that belongs to the class of calcium channel blockers. It works by relaxing the blood vessels to allow easy flow of blood
| Cytarabine is a medication used in the management and treatment of leukemias and lymphomas. It belongs to the antimetabolic group of medications. This activity reviews the indications, action, and contraindications for cytarabine as a valuable agent in treating acute myeloid leukemia (and other leukemias. | Carboplatin is an alkylating agent used to treat advanced ovarian cancer.Carboplatin is indicated in combination with an established combination of chemotherapeutic agents for the initial treatment of advanced ovarian carcinoma. Carboplatin is also indicated for the palliative treatment of ovarian carcinoma, recurrent after prior chemotherapy.
| Zoledronic acid is used to treat high levels of calcium in the blood that may be caused by certain types of cancer.
|
Reviews
There are no reviews yet.